Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler.
Pharmacy Department, Drug Clinical Area, Hospital Universitari i Politècnic La Fe, Valencia, Spain Department of Dermatology, Hospital Quirón Valencia, Valencia, Spain Pharmacy Department, Drug Clinical Area, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Juan Eduardo
JE
Megías-Vericat
José María
JM
Ricart
Hugo
H
Ribes-Artero
José Luis
JL
Poveda
D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D000067548:Dermal Fillers / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D007269:Injections, Intra-Arterial / Q000009:adverse effects*; D009666:Nose / Q000098:blood supply*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000067548:Dermal Fillers; D014665:Vasodilator Agents; D006820:Hyaluronic Acid; D000527:Alprostadil